Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Earum Pharmaceuticals Ltd - 542724 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 5Th November, 2022

 Earum Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2022 ,inter alia, to consider and approve This is to inform you that a meeting of the Board of Directors of the Company will be held on 5th November, 2022 at 3:00 P.M. at the registered office of the Company situated at Survey A-1106, Empire Business Hub Near AUDA Water Tank, Science City Road, Sola Ahmedabad - 380 060 inter alia, to consider and approve the Unaudited Financial Results of the Company for the Half Year ended on 30th September, 2022 along with Limited Review Report. Please take note of the same and oblige.
15-10-2022
Bigul

Earum Pharmaceuticals Ltd - 542724 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 With reference to the captioned subject, we hereby submit the confirmation Certificate received from M/s. Bigshare Services Private Limited, Registrar and Share Transfer Agent (RTA) as per Regulation 74(5) of the Securities and Exchange Board India (Depository and Participant) Regulations, 2018 for the Quarter ended on 30th September, 2022.
14-10-2022
Bigul

Earum Pharmaceuticals Ltd - 542724 - Statement Of Investor Complaints For The Quarter Ended September 2022

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- BHUMISHTH NARENDRABHAI PATELDesignation :- Managing Director / Whole Time Director
14-10-2022
Bigul

Earum Pharmaceuticals Ltd - 542724 - Closure of Trading Window

 Pursuant to Clause 4 of Schedule B of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time and Company's Code of Internal Procedures and Conduct for Prevention of Insider Trading in Securities, this is to inform that the trading window for dealing in Equity Shares of the Company by the Insiders will be closed from Saturday, 1st October, 2022 till 48 hours after the declaration and publication of Unaudited Financial Results for the for the Quarter and half year ended on 30th September, 2022. Please take note of the same and oblige.
30-09-2022
Bigul

Earum Pharmaceuticals Ltd - 542724 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Payal B Patel
08-09-2022
Bigul

Earum Pharmaceuticals Ltd - 542724 - Appointment of Company Secretary and Compliance Officer

 Pursuant to second proviso to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors of the Company, in their meeting held on 7th September, 2022 has appointed Ms. Madhuri Mistry as the Company Secretary and Compliance Officer of the Company w.e.f. 7th September, 2022 The brief profile of Ms. Madhuri Mistry is as below:
07-09-2022
Bigul

Earum Pharmaceuticals Ltd - 542724 - Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. 7Th September, 2022

 1. Issue of 24,67,16,400 Equity Shares of face value of Rs. 2/- at par aggregating of Rs. 49,34,32,800/- to all existing members of the Company on rights ('Rights Issue'). The brief term of right issue is approved by the Board is annexure herewith as Annexure - I. 2. The formation of a Committee of Directors to decide matters relating to the Rights Issue ('Rights Issue Committee') which includes, inter alia, to decide or alter the treatment to be given to fractional entitlements, if any to make any application to the regulatory authorities as may be required, determine the terms and conditions of the Right Issue including structure and timing of the issue. 3. Appointment of Ms. Madhuri Mistry as the Company Secretary and Compliance Officer of the Company w.e.f. 7th September, 2022.
07-09-2022
Bigul

Earum Pharmaceuticals Ltd - 542724 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Bhumishth N Patel
07-09-2022
Bigul

Earum Pharmaceuticals Ltd - 542724 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Wednesday, 7Th September, 2022

 Earum Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/09/2022 ,inter alia, to consider and approve Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a meeting of the Board of Directors of the Company will be held on Wednesday, 7th September, 2022 at 3:00 P.M. at A-1106, Empire Business Hub, Near AUDA Water Tank, Science City Road, Sola, Ahmedabad - 380 060, to discuss and consider issue of Equity Shares of the Company on Rights basis. Further, pursuant to Clause 4 of Schedule B of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time and Company's Code of Internal Procedures and Conduct for Prevention of Insider Trading in Securities, this is to inform that the trading window for dealing in Equity Shares of the Company by the Insiders will be closed from Saturday, 3rd September, 2022 till 48 hours after the conclusion of the meeting.
02-09-2022
Bigul

Earum Pharmaceuticals Ltd - 542724 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Bhumishth N Patel
02-09-2022
Next Page
Close

Let's Open Free Demat Account